Shionogi

Contact
shionogi.co.jp
+81-06-6202-2161

Shionogi & Co., Ltd.

1-8, Doshomachi 3-chome, Chuo-ku
541-0045 Ōsaka
Japan
+81-06-6202-2161
shionogi.co.jp
Contact
Profile News
Contact

About Shionogi

Shionogi & Co., Ltd. is a major research-driven Japanese pharmaceutical manufacturer. The company’s primary businesses are research and development, manufacturing, marketing, and import and export sales of pharmaceuticals and diagnostics. Shionogi follows a basic policy of continually providing the superior medicines essential to people’s health.

Read more about Shionogi
Facts about Shionogi
  • Focus : Manufacturer
  • Industry : Pharma

News about Shionogi

Shionogi

04-Nov-2011 | business & finance

MorphoSys and Shionogi Agree Three-Year Extension of Research Partnership

MorphoSys AG announced that it has expanded its current licence agreement withShionogi & Co., Ltd., Osaka, Japan. The expanded agreement covers the use of ...

Read news
Shionogi

03-Nov-2011 | research and development

Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi

Evotec AG announced the achievement of specific success criteria in a multiple target drug discovery collaboration with Shionogi & Co Ltd. and the receipt ...

Read news
Shionogi

31-Mar-2011 | business & finance

Graffinity Enters into Drug Discovery Collaboration with Shionogi

Graffinity Pharmaceuticals GmbH announced that it has entered into a research collaboration with Osaka, Japan based Shionogi & Co., Ltd. Under the terms of ...

Read news
Shionogi

07-Oct-2010 | business & finance

Evotec and Shionogi Enter Fragment-based Drug Discovery Alliance

Evotec AG announced that it has entered into a multiple target drug discovery collaboration with Shionogi & Co Ltd., to identify small molecule modulators ...

Read news
Shionogi

08-Sep-2010 | business & finance

Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan

Stallergenes S.A. has announced the signing of exclusive partnership agreements with Shionogi & Co., Ltd. for two sublingual allergen immunotherapy tablet ...

Read news
Shionogi

30-Sep-2008 | business & finance

Shionogi Extends Research Partnership with MorphoSys

MorphoSys AG announced that Shionogi & Co., Ltd. has elected to extend its current license agreement covering the use of MorphoSys's HuCAL technology in ...

Read news
Shionogi

03-Sep-2008 | business & finance

Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.

Shionogi & Co., Ltd. and Sciele Pharma, Inc. announced that they have entered into a definitive agreement under which Shionogi & Co., Ltd. will acquire ...

Read news
Show more news about Shionogi

Here you will find Shionogi & Co., Ltd.